Literature DB >> 23012116

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Annotations of colorectal lesions.

M Vieth1, P Quirke, R Lambert, L von Karsa, M Risio.   

Abstract

Multidisciplinary, evidence-based guidelines for quality assurance in colorectal cancer screening and diagnosis have been developed by experts in a project coordinated by the International Agency for Research on Cancer. The full guideline document covers the entire process of population-based screening. It consists of 10 chapters and over 250 recommendations, graded according to the strength of the recommendation and the supporting evidence. The 450-page guidelines and the extensive evidence base have been published by the European Commission. The chapter on quality assurance in pathology was supplemented by an annex describing in greater detail some issues raised in the chapter, particularly details of special interest to pathologists. The content of the annex is presented here to promote international discussion and collaboration by making the issues discussed in the guidelines known to a wider professional and scientific community. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 23012116     DOI: 10.1055/s-0032-1309798

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  11 in total

1.  European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.

Authors:  L von Karsa; J Patnick; N Segnan; W Atkin; S Halloran; I Lansdorp-Vogelaar; N Malila; S Minozzi; S Moss; P Quirke; R J Steele; M Vieth; L Aabakken; L Altenhofen; R Ancelle-Park; N Antoljak; A Anttila; P Armaroli; S Arrossi; J Austoker; R Banzi; C Bellisario; J Blom; H Brenner; M Bretthauer; M Camargo Cancela; G Costamagna; J Cuzick; M Dai; J Daniel; E Dekker; N Delicata; S Ducarroz; H Erfkamp; J A Espinàs; J Faivre; L Faulds Wood; A Flugelman; S Frkovic-Grazio; B Geller; L Giordano; G Grazzini; J Green; C Hamashima; C Herrmann; P Hewitson; G Hoff; I Holten; R Jover; M F Kaminski; E J Kuipers; J Kurtinaitis; R Lambert; G Launoy; W Lee; R Leicester; M Leja; D Lieberman; T Lignini; E Lucas; E Lynge; S Mádai; J Marinho; J Maučec Zakotnik; G Minoli; C Monk; A Morais; R Muwonge; M Nadel; L Neamtiu; M Peris Tuser; M Pignone; C Pox; M Primic-Zakelj; J Psaila; L Rabeneck; D Ransohoff; M Rasmussen; J Regula; J Ren; G Rennert; J Rey; R H Riddell; M Risio; V Rodrigues; H Saito; C Sauvaget; A Scharpantgen; W Schmiegel; C Senore; M Siddiqi; D Sighoko; R Smith; S Smith; S Suchanek; E Suonio; W Tong; S Törnberg; E Van Cutsem; L Vignatelli; P Villain; L Voti; H Watanabe; J Watson; S Winawer; G Young; V Zaksas; M Zappa; R Valori
Journal:  Endoscopy       Date:  2012-12-04       Impact factor: 10.093

2.  Interobserver variability amongst gastrointestinal pathologists in assessing prognostic parameters of malignant colorectal polyps: a cause for concern.

Authors:  A Davenport; J Morris; S A Pritchard; E Salmo; M Scott; N Y Haboubi
Journal:  Tech Coloproctol       Date:  2016-08-13       Impact factor: 3.781

3.  Factors of Never Screened with Faecal Occult Blood Test in Public Primary Care Facilities.

Authors:  Mohd Fazeli Sazali; Syed Sharizman Syed Abdul Rahim; Richard Avoi; Mohd Rohaizat Hassan; Firdaus Hayati; Zahir Izuan Azhar; Mohammad Saffree Jeffree; Khamisah Awang Lukman; Naing Oo Tha; Helmy Sajali; Azman Atil; Muhammad Aklil Abd Rahim
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

4.  Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma.

Authors:  Keying Che; Yang Zhao; Xiao Qu; Zhaofei Pang; Yang Ni; Tiehong Zhang; Jiajun Du; Hongchang Shen
Journal:  Onco Targets Ther       Date:  2017-02-20       Impact factor: 4.147

5.  Prognostic and pathological impact of tumor budding in gastric cancer: A systematic review and meta-analysis.

Authors:  Yi-Xian Guo; Zi-Zhen Zhang; Gang Zhao; En-Hao Zhao
Journal:  World J Gastrointest Oncol       Date:  2019-10-15

6.  Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam.

Authors:  Tu Van Dao; Chu Van Nguyen; Quang Tien Nguyen; Ha Thi Ngoc Vu; Huyen Thi Phung; Oanh Thi Bui; Dung Khac Nguyen; Bang Viet Luong; Thuan Van Tran
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

7.  Expression of TSP50, SERCA2 and IL-8 in Colorectal Adenoma and Carcinoma: Correlation to Clinicopathological Factors.

Authors:  Heba M K Youssef; Dina A Radi; Marwa A Abd El-Azeem
Journal:  Pathol Oncol Res       Date:  2021-10-21       Impact factor: 3.201

Review 8.  Tumor budding in upper gastrointestinal carcinomas.

Authors:  Viktor H Koelzer; Rupert Langer; Inti Zlobec; Alessandro Lugli
Journal:  Front Oncol       Date:  2014-08-14       Impact factor: 6.244

9.  Tumor Budding, uPA, and PAI-1 in Colorectal Cancer: Update of a Prospective Study.

Authors:  Bruno Märkl; Jochen Hardt; Simon Franz; Tina Schaller; Gerhard Schenkirsch; Bernadette Kriening; Reinhard Hoffmann; Stefan Rüth
Journal:  Gastroenterol Res Pract       Date:  2017-02-12       Impact factor: 2.260

10.  Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.

Authors:  P García-Alfonso; R García-Carbonero; J García-Foncillas; P Pérez-Segura; R Salazar; R Vera; S Ramón Y Cajal; J Hernández-Losa; S Landolfi; E Musulén; M Cuatrecasas; S Navarro
Journal:  Clin Transl Oncol       Date:  2020-05-16       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.